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Abstract
The development of heterologous overexpression systems for soluble proteins has greatly advanced the study of the structure/function
relationships of these proteins and their biotechnological and pharmaceutical applications. In this paper we present an overview on several
aspects of the use of the methylotrophic yeast Hansenula polymorpha as a host for heterologous gene expression. H. polymorpha has been
successfully exploited as a cell factory for the large-scale production of such components. Stable, engineered strains can be obtained by
site-directed integration of expression cassettes into the genome, for which various constitutive and inducible promoters are available to
control the expression of the foreign genes. New developments have now opened the way to additional applications of H. polymorpha, which
are unprecedented for other organisms. Most importantly, it may be the organism of choice for reliable, large-scale production of
heterologous membrane proteins, using inducible intracellular membranes and targeting sequences to specifically insert these proteins stably
into these membranes. Furthermore, the use of H. polymorpha offers the possibility to accumulate the produced components into specific
compartments, namely peroxisomes. These organelles are massively induced during growth of the organism on methanol and may occupy
up to 80% of the cell volume. Accumulation inside peroxisomes prevents undesired modifications (e.g. proteolytic processing or
glycosylation) and is also in particular advantageous when proteins are produced which are toxic or harmful for the host. © 2000 Elsevier
Science Inc. All rights reserved.
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1. Introduction
Heterologous production of biologically active proteins
has become an important tool in fundamental and applied
research. At present a variety of hosts (ranging from bacte-
ria to higher eukaryotes) have been explored for their ca-
pacity to produce heterologous proteins. In general, micro-
organisms are favored, because they have short generation
times, are easy to grow and are readily accessible to genetic
manipulations. Yeasts are often preferred for the production
of plant or animal proteins, because in these organisms
protein modifications typical for eukaryotes normally occur.
These modifications (e.g. glycosylation, acylation, phos-
phorylation, formation of disulfide bonds; [1]) are often
essential for the function and/or stability of the protein.
Initially, Saccharomyces cerevisiae has been the yeast spe-
cies of choice for foreign protein production for obvious
reasons; its genetics were well developed and the organism
is generally regarded as save. Despite successful applica-
tions specific disadvantages in the use of S. cerevisiae have
also been encountered. These include among others the
oft-observed instability of the engineered strains, undesired
hyperglycosylation and relatively low yields, due to the lack
of strong promoters.
The methylotrophic yeast Hansenula polymorpha has
been recognized as an attractive alternative. Originally,
methylotrophic yeasts have been isolated for the production
of single-cell protein at the expense of cheap carbon
sources, like methanol. Studies on the physiology, biochem-
istry and ultrastructure of these yeasts revealed that metha-
nol is oxidized by a hydrogen-peroxide producing alcohol
oxidase (AOX), which is localized in peroxisomes. In these
organelles also catalase, which decomposes the hydrogen-
peroxide produced, and dihydroxyacetone synthase
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(DHAS), which catalyzes the first step in the assimilatory
pathway, are present. Other enzymes involved in methanol
assimilation (enzymes of the xylulose-5-phosphate pathway
[2]) or dissimilation [(formaldehyde dehydrogenase (FdDH)
and formate dehydrogenase (FMD)] are cytosolic [3].
A striking feature of methanol-grown yeasts is the ex-
cessive proliferation of peroxisomes. In methanol-limited
continuous cultures these organelles can occupy up to 80%
of the total cell volume [3]. In such cells AOX and DHAS
may constitute over 60% of the total cell protein, which
illustrates that the genes encoding these proteins are con-
trolled by very strong promoters. Also, the expression of the
genes encoding FdDH and FMD are under control of strong,
inducible promoters [4,5].
H. polymorpha has some specific advantages over other
methylotrophic yeasts (Candida boidinii, Pichia pastoris),
being more thermotolerant and capable to grow at higher
rates on simple, defined media. The relatively high optimal
growth temperature for H. polymorpha (37–43°C vs. 30°C
for C. boidinii, P. pastoris, and S. cerevisiae) may be fa-
vorable for the production of mammalian (including human)
proteins and furthermore has the advantage that it allows a
better cooling management and reduces the risk of contam-
inations in large scale fermentations.
In this paper recent relevant developments on the use of
H. polymorpha as a reliable, efficient cell factory are dis-
cussed.
2. Tools for introducing (heterlogous) genes in H.
polymorpha
2.1. Transformation procedures
The molecular techniques for the manipulation of H.
polymorpha have now been advanced to a level similar to
those available for S. cerevisiae. Efficient and reliable trans-
formation procedures for H. polymorpha by using electro-
poration have been developed by Faber et al. [6] (transfor-
mation frequency of 1.7 3 106 /mg DNA). Optimal results
are obtained by using batch cells from the midexponential
growth phase that are pretreated with the reducing agent
DTT to weaken the cell wall. Upon addition of plasmid DNA,
an electrical pulse is applied that allows entry of the DNA
molecules. The electroporation procedure is now the method of
choice for efficient H. polymorpha transformations.
2.2. Expression vectors
An essential tool for the selection of transformants is the
availability of suitable genetic markers. Various auxotro-
phic H. polymorpha mutants (leu, ura, trp, and ade) have
been generated and vectors have been constructed that carry
homologous (LEU1.1, URA3, TRP3, and ADE11) or heter-
ologous (LEU2, URA3 from S. cerevisiae, LEU2 from Can-
dida albicans) genes that functionally complement these
mutants [7–9]. Also, genes that confer resistance against
G418 [10], phleomycin [11] or Zeocin [12] have success-
fully been used as dominant selection markers in H. poly-
morpha.
Several H. polymorpha autonomously replicating se-
quences (HARS) and other DNA-fragments that promote
autonomous replication of plasmids in H. polymorpha have
been isolated and are currently being used in various vectors
[8,13–18]. The DNA fragment that contains the S. cerevi-
siae LEU2 gene as the selectable marker has also been
shown to promote autonomous replication in H. polymor-
pha [18].
Stable transformants, which do not have to be grown
under selective growth conditions, are obtained upon inte-
gration of plasmid DNA into the genome. For H. polymor-
pha both legitimate and illegitimate integrations have been
reported.
Targeted integration can be obtained both by single or
double cross-over recombination, resulting in additive inte-
gration or gene replacement, respectively. Integration is
routinely achieved by using linearized plasmids containing
DNA sequences from homologous genes, which are specif-
ically targeted to the corresponding sites in the genome [19].
Most commonly used are the genes encoding alcohol oxi-
dase (AOX) or amine oxidase (AMO).
An elegant disruption-replacement method for targeted
single copy integration has recently been described [20].
First, the TRP3 gene of an H. polymorpha leu1.2 strain was
disrupted by insertion of the S. cerevisiae LEU2 gene. The
genotype of the resulting strain is trp3D LEU2. The trp3D
allele in this strain and the tightly linked AOX gene can
subsequently be replaced by a DNA fragment containing
part of the TRP3 gene and expression cassettes containing
PAOX. The proper integrants, which are again TRP3 leu2,
can easily be selected. An attractive advantage of this pro-
cedure is that no vector sequences are introduced into the
genome of the resulting strains. Moreover, the resulting
strain is again leu1.2, which offers the possibility to intro-
duce additional genes in the same strain using LEU2 as
selectable marker.
Single- or multicopy integrants can easily be selected by
using an H. polymorpha leu1.1 strain and a vector contain-
ing S. cerevisiae LEU2 as selectable marker. Because mul-
ticopy integrants form large colonies on selective media,
whereas single-copy integrants develop relatively small
ones. The latter is due to the fact that the S. cerevisiae gene
does not fully complement the leucine auxotrophy in H.
polymorpha. A similar strategy can be followed by using an
H. polymorpha ura3 strain and the S. cerevisiae URA3 gene.
These strategies have enabled the generation of strains con-
taining more than 100 copies of the vector per genome
equivalent [13,21].
Another strategy [22] to select strains with multiple in-
tegrations is the use of resistance markers and several con-
secutive selection rounds by using increasing concentrations
of the antibiotic.
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2.3. Inducible and constitutive promoters
Like other methylotrophic yeasts, H. polymorpha pos-
sesses several strong promoters, which are induced during
growth on methanol. The promoters of the alcohol oxidase
(PAOX), dihydroxyacetone synthase (PDHAS), and formate
dehydrogenase (PFMD) genes are most commonly used to
control heterologous gene expression [4,5,23,24].
The PAOX promoter is fully repressed by glucose or
ethanol and strongly induced by methanol. When glucose or
ethanol concentrations are low (e.g. in late exponential
batch cultures or carbon-limited continuous cultures), PAOX
is derepressed, resulting in low AOX expression levels.
Derepression also occurs when cells grow in batch cultures
containing glycerol or xylitol as sole carbon source. In
glycerol or xylitol grown cells the AO levels can reach up to
30% to 70% of the maximal values. The PDHAS and PFMD
are also strongly induced during growth on methanol and
the kinetics of derepression resemble that of PAOX. These
strong regulated promoters are, therefore, tools of choice to
control high gene expression levels in H. polymorpha.
In constructed strains that are not able to grow on meth-
anol (e.g. upon gene replacement at the AOX-locus) induc-
tion of the PAOX, PDHAS, and PFMD can be readily achieved
by using continuous cultures and mixed substrates (e.g.
glucose/methanol or glucose/choline mixtures). In the latter
case the actual inducer is formaldehyde that is released from
choline during the metabolism of this nitrogen source [25].
As an independent, inducible promoter the amine oxi-
dase promoter (PAMO) can be used. Amine oxidase (AMO)
is a peroxisomal enzyme involved in oxidation of primary
amines (methylamine, ethylamine), which can be utilized as
sole source of nitrogen by H. polymorpha. PAMO is induced
by these amines and fully repressed by ammonium [26].
Compared to the PAOX the PAMO is much weaker (up to
20% of PAOX).
Also the promoters of three nitrate assimilation genes,
YNT1, YNI1, and YNR1, which are induced by nitrate but
strongly repressed by ammonium may serve as additional
tools for controlling heterologous gene expression [27].
Furthermore, the recently identified promoter of the H.
polymorpha PHO1 gene encoding a repressible acid phos-
phatase [28] may be suitable for the control of heterologous
genes that have to be expressed at relatively moderate lev-
els.
By using the above promoters various attractive induc-
tion strategies can now be designed. For instance, in case of
the production of harmful proteins, first biomass can be
generated under repressing conditions, followed by an al-
teration in the composition of the growth medium, thereby
inducing the expression of the heterologous gene.
Strong constitutive promoters have been identified in H.
polymorpha as well. These include the promoters of the
genes encoding a plasma membrane ATPase (PMA1) [24]
or encoding the translation elongation factor-1a (TEF1/
TEF2; [29] and J.A.K.W. Kiel, unpublished results).
In the course of our studies on the biogenesis of peroxi-
somes, 10 H. polymorpha PEX genes have been cloned,
which all encode proteins essential for peroxisome biogen-
esis. The promoters of the PEX genes are relatively weak.
Moreover, most of them are constitutively expressed or only
slightly induced upon a shift of cells to peroxisome-induc-
ing growth conditions [30–32]. As a consequence these
promoters are not very suitable to control heterologous gene
expression.
2.4. Sorting of heterologous proteins to specific
subcellular locations
By using the above tools, it is possible to introduce
foreign genes in H. polymorpha and to carefully control
their expression. H. polymorpha has however an additional
attractive advantage that is unprecedented for other cell
factories. This includes the possibility to select specific
subcellular compartments as optimal targets for specific
proteins. Targeting signals have now been identified for
various cell compartments of H. polymorpha (mitochondri-
on, peroxisome, endoplasmic reticulum, secretory pathway,
vacuole). Such signals can easily be added to any protein,
simply by constructing chimeric genes encoding fusion pro-
teins that contain a (homologous or heterologous) targeting
signal. If necessary, cleavage of the protein and the signal
can be achieved in vivo or in vitro by using highly specific
endopeptidases (e.g. the TEV protease [33] or factor Xa
[34]) provided that the appropriate cleavage site is intro-
duced between the protein and the signal sequence.
Below some examples are given of the advantage of the
sorting the of heterologous proteins to specific target or-
ganelles.
2.5. Accumulation in the peroxisomal matrix
Soluble proteins can be specifically targeted to the per-
oxisomal matrix. These organelles have the capacity to
accumulate proteins to very high concentrations. It should
be stressed that massive peroxisome proliferation can also
be induced under conditions where the organelles are not
essential for growth (e.g. in carbon-limited chemostat cul-
tures by using mixed substrates; see above). This implies
that the storage capacity of the organelles can in principle be
used without affecting the viability of the cell. The advan-
tage of storage in the peroxisomal matrix is the absence of
protein modifying enzymes in this cell compartment (e.g.
mediating phosphorylation, glycosylation, or proteolytic
processing), which may give rise to undesired modifications
upon production in the cytosol or during passage in the
endoplasmic reticulum. The absence of proteolytic activity
in the peroxisomal matrix of H. polymorpha is highly ad-
vantageous in case of heterologous proteins that are relatively
unstable and/or are sensitive to proteolytic degradation.
Accumulation in peroxisomes may also be the method of
choice for producing components that are toxic for the host;
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compartmentalization in peroxisomes will prevent that such
components can exert their toxic activity.
Targeting of heterologous proteins to the peroxisomal
matrix can be mediated by addition of one of the two known
peroxisomal targeting signals, PTS1 or PTS2 [35,36]. The
PTS1 consists of only three amino acids and is present at the
extreme carboxyterminus of many peroxisomal matrix pro-
teins. The first identified PTS1, -SKL-COOH), was found in
firefly luciferase. Later studies revealed that several amino
acid substitutions are allowed in this sequence [37]. In H.
polymorpha the enzymes AOX (-ARF), DHAS (-NKL),
catalase (-SKI), and the peroxisomal matrix protein Pex8p
(-AKL; see Fig. 1) contain a PTS1, that have been shown to
be functional in targeting reporter proteins to peroxisomes
of H. polymorpha.
The successful use of a PTS1 to accumulate large
amounts of a heterologous protein in H. polymorpha per-
oxisomes has been demonstrated [30,38]. The PTS1 (SKL-
COOH) was added to the carboxyterminus of a fusion
protein, which consisted of human insulin-like growth fac-
tor II and a carrier protein. Overproduction of this protein,
which was properly targeted to the peroxisomes, resulted in
levels of .20% of the total cell protein [34].
The PTS2 is present at the N-terminus of peroxisomal
matrix proteins and characterized by the consensus se-
quence (R/K)(L/V/I)X5(H/Q)(L/A) [35,36]. In H. polymor-
pha this signal has been found in AMO (RLX5QA) and
Pex8p (KLX5QL). Import of PTS1 proteins is efficient un-
der all growth conditions tested so far. However, for effi-
cient import of PTS2 proteins the cells have to be grown in
media containing primary amines as sole nitrogen source
(i.e. conditions that induce expression of the AMO gene),
possibly because only under these conditions the genes
encoding essential components involved in PTS2 protein
import are sufficiently expressed [18].
2.6. Intracellular membranes
Of special interest is the establishment of expression
systems for overproduction of heterologous membrane pro-
teins. Large-scale production of foreign membrane proteins
is troublesome in all systems used to date. On the other
hand, the production of membrane proteins (e.g. human
hormone receptors) is of major importance in fundamental
studies for obtaining sufficient amounts of proteins for func-
tional studies or for three-dimensional structure determina-
tions. Membrane proteins form a large and important class
of proteins. Analysis of the available eukaryotic genomes
shows that at least 30% of the open reading frames encode
membrane proteins. Moreover, membrane protein malfunc-
tioning is the cause of many inherited diseases in man.
Hence, the availability of a reliable system to overproduce
these proteins is of great medical interest, e.g. for rational
drug design. H. polymorpha can fill in the existing gap in
membrane protein production systems. The organism has
the advantage that excessive amounts of peroxisomal mem-
branes can be produced that largely lack homologous pro-
teins. These membranes are induced during incubation of
cells on oleic acid-containing media (H. polymorpha is not
capable to grow on oleic acid) [39], but do not form or-
ganelles and thus have no matrix contents. Therefore, these
membranes are ideal targets to accumulate foreign mem-
brane proteins. Because these membranes are peroxisomal in
nature, sorting can be mediated by a specific targeting signal of
a homologous H. polymorpha peroxisomal membrane protein.
Efficient sorting of specific human membrane proteins that
were biologically active has already been achieved by using
the N-terminus of Pex3p [32] as sorting signal.
2.7. Secretion
Secretion of an (over)produced heterologous protein is
often favorable, because it facilitates the recovery of the
protein from the culture fluid. Also in this respect H. poly-
morpha offers a distinct advantage, because this yeast spe-
cies does not secrete significant amounts of proteins. There-
fore, the secreted heterologous protein can be recovered in
a relatively pure state from the culture medium (.90% of
total extracellular protein). Another important aspect of
protein secretion is that in the secretory pathway of eu-
karyotes several protein modifications take place, which are
often essential for the activation of proteins (proteolytic
processing, formation of the correct disulphide bonds, gly-
cosylation etc.).
To establish secretion it is necessary to fuse the protein
of interest to an N-terminal presequence (also called leader
Fig. 1. Immunocytochemical localization of bacterial b-lactamase in per-
oxisomes of a Hansenula polymorpha strain producing PTS1-containing
b-lactamase fusion protein (AKL-COOH) [30]. The electronmicrograph
shows a thin section of an aldehyde-fixed cell decorated with anti-b-
lactamase antibodies and secondairy antibodies conjugated with gold. Ab-
breviations: M, mitochondrion; N, nucleus; P, peroxisome. The bar repre-
sents 0.5 mm.
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sequence) that directs the protein to the secretory pathway.
Leader sequences have a tripartite structure, consisting of a
positively charged region at the extreme N-terminus, a cen-
tral hydrophobic stretch of 7 to 15 amino acids, followed by
a polar region (3–7 amino acids) that contains the recogni-
tion site for a specific ER-located leader peptidase. The
cleavage site is characterized by small side chains at posi-
tion 21 and 23 relative to the residue where the prese-
quence is processed. Some secreted proteins contain, next to
the presequence, a proregion. These preprosequences are
processed twice. The presequence is cleaved by the ER-
leader peptidase, whereas the second one is cleaved in the
late Golgi by a functional equivalent of S. cerevisiae Kex2
[40,41]. Two basic residues (KR or RR) precede the second
cleavage site.
So far only one homologous H. polymorpha secretion
signal is known, namely the presequence of repressible acid
phosphatase (PHO1). This presequence is a good candidate
to mediate secretion of heterologous proteins in H. poly-
morpha [28], but has not been tested yet.
Of the various heterologous secretion signals available to
drive protein secretion in H. polymorpha, the preprose-
quence of S. cerevisiae mating factor 1a is mostly used
[42,43,44]. As illustrated in Table 1, this signal invariable
resulted in efficient secretion in H. polymorpha.
Other heterologous prepro-sequences, which have suc-
cessfully been used in H. polymorpha are derived from
Schwanniomyces occidentalis glucoamylase [5,45], Carci-
nus maenas hyperglycemic hormone [45], Aspergillus niger
glucoamylase [20], Kluyveromyces lactis killer toxin [20],
and Kluyveromyces marxianus inulinase [46] (see Table 1).
Expression of S. cerevisiae SUC2 [47], which codes for
invertase including its authentic leader sequence, resulted in
efficient secretion of Sc-invertase protein by H. polymorpha
[48]. Also upon fusion of the Sc-invertase presequence to
Ct-a-galactosidase (see Table 1), the heterologous protein
was successfully secreted. However, when the Sc-invertase
leader sequence was fused to human tyroid peroxidase this
signal was not effective (Table 1). Experiments in which
different leader sequences were compared with respect to
their capacity to direct a protein to the secretory pathway of
H. polymorpha, suggested that the search for the most
efficient leader sequence is often a matter of trial and error
(Table 1).
Several examples have been described of proteins (rang-
ing from fungal to human ones) that carried the authentic,
endogenous presequence and were properly directed to the
secretory pathway of H. polymorpha and subsequently se-
creted (see Table 1).
Although the secretory pathway is highly conserved in
eukaryotes, not all heterologous targeting sequences func-
tion efficiently in H. polymorpha.
Proper translation of the presequence could be hampered
due to the presence of rare codons for H. polymorpha [20]
resulting in a decrease in translation rate or even in a
translation block. Adjustments in the coding regions can
solve such problems. Incorrect or incomplete processing of
the pre(pro)sequences can also result in reduced secretion
efficiency. Examples in H. polymorpha are the secretion of
human urinary plasmalogen activator (slow processing of
the prosequence) or leech hirudin (incorrect processing re-
sulting in one amino acid extension) [20,45]. These prob-
lems are generally related to insufficient recognition of the
cleavage site(s) by the processing peptidases. A rational
design of pre(pro)sequences and processing sites based on
empirical rules as postulated by von Heijne [49], has proven
to be effective for S. occidentalis preprosequences [45], and
could be applied for H. polymorpha as well.
Proper glycosylation is another important aspect of the
production of functional proteins in heterologous hosts. The
Table 1
Heterologous proteins secreted by Hansenula polymorpha
Proteina Secretion signalb Secretion yieldc Reference
An-Glucose oxidase Sc-aMF 111/11111 43/55
Hs-Kunitz-PI Sc-aMF 111 56
Aprotinin Sc-aMF 11/111d 11
Sc-Invertase endogenous 11111e 48
Ct-a-Galactosidase Sc-invertase 111/1f 57/58
Hs-Tyroid Peroxidase Sc-aMF 111g 44
Hs-Tyroid Peroxidase Sc-invertase 2 44
Hs-Tyroid Peroxidase endogenous 2 44
Hs-a1-Antitrypsin Km-inulinase 1111h 59
Hm-Huridin Sc-aMF 111 45
Hm-Huridin So-GAM 1111 45
Hm-Huridin Cm-CHH 1111 45
Hs-Urokinase Sc-aMF 1111 20
Hs-Urokinase KI-KTS 11111 20
Hs-Urokinase An-GAS 1 20
Hs-Urokinase Hs-OLS 11111 20
Aa-Cellulase-I endogenous 11111 51
Hi-Cellulase-II endogenous 11111 51
Aa-Galactanase endogenous 11111 51
TI-Lapase I endogenous 11 51
Aa-Polygalacturonase endogenous 11 51
HI-Xylanase-I endogenous 11111 51
So-Glucoamylase endogenous 1111 5
HBsAG-M endogenous 11e 60
a
Abbreviations: Hs, Homo sapiens; Sc, Saccharomyces cerevisiae; Aa,
Aspergillus aculeatus. Hi, Humicola insolens; Ct, Cyamopsis tetra-
gonoloba. So, Schwannomiomyces occidentalis; An, Aspergillus niger; s,
Spinach; HBsAG-M, Hepatitis B surface antigen middle; Hm, Hurido
medicinalis; Kunitz-PI, protease inhibiter domain; TI, Thermomyces
lanuginosus.
b Abbreviations: Km, Kluyveromyces marxianus; Sc-aMF, S. cerevisiae
prepro a mating factor; KI-KTS, Kluyveromyces lactis killer toxin; An-GAS,
Aspergillus niger glucoamylase; Hs-OLS, Human lysozyme; So-GAM,
Schwanniomyces occidentalis glucoamylase; Cm-CHH, Carcinus maenas
hyperglycemic hormone.
c1–11111 is from 100 mg/l to at least 1g/l product, otherwise based
on activity comparison.
dOver 80% extracellular; dependent on the form of the protein.
ePeriplasmic space.
fDeglycosylation necessary for activity.
gNot active membrane bound.
hOver 80% extracellular.
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majority of human therapeutic proteins are glycoproteins,
but improper glycosylation of heterologous proteins may
cause an immunogenic response. Hence, it is of utmost
importance that the glycosylation patterns resemble those
present in the authentic proteins.
In S. cerevisiae, hyperglycosylation has often been ob-
served (i.e. heterogenous glycosylation by addition of more
than 40 mannose residues to the glycosylation core). In
general, the overall length of the mannose chains is lower in
H. polymorpha compared to S. cerevisiae and only few
cases of hyperglycosylation have been reported in H. poly-
morpha [50,51]. Hence, H. polymorpha may be a much
better candidate to produce human therapeutic proteins
compared to S. cerevisiae.
3. Conclusion
At present a range of heterologous expression systems is
available to cover the need for various proteins to be used
for fundamental structure/function analysis and for biotech-
nological and pharmaceutical purposes. Among these sys-
tems, H. polymorpha is now recognized as a very suitable
one. The first recombinant products produced in H. poly-
morpha have now passed the clinical examinations and are
being launched on the market (e.g. a novel Hepatitis B
vaccine) [52,53] and others will soon follow. Also, the use
of H. polymorpha as a biocatalyst [54] will be extended in
the near future in particular when the option to anchor
factors involved in the activation of complex heterologous
proteins at the periplasmic space or outer cell wall will be
realized. This strategy allows the creation of regeneratable
systems in continuous cultures.
However, the real challenge for the next coming years is
to further develop the high potential of the organism for the
production of various membrane proteins (including hu-
man). The need for such a system is obvious and would
strongly stimulate the functional and structural analyses of
this important class of proteins.
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